SPOTLIGHT: Canadians prepare OxyContin lawsuit

OxyContin class action lawsuit
A Canadian lawyer is putting the finishing touches on a class-action lawsuit that pits patients hooked on the pain drug OxyContin against its maker, Purdue Pharma. To be filed in Nova Scotia next week, the suit will claim that the company "misinformed the public and physicians" about OxyContin's suitability for long-term use. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.